PR on Friday February 28
ALT
https://finance.yahoo.com/quotes/alt
Altimmune Completes First Development Milestone Toward a Single-Dose Intranasal COVID-19 Vaccine
https://www.globenewswire.com/news-...-Single-Dose-Intranasal-COVID-19-Vaccine.html
ALT
https://finance.yahoo.com/quotes/alt
Altimmune Completes First Development Milestone Toward a Single-Dose Intranasal COVID-19 Vaccine
https://www.globenewswire.com/news-...-Single-Dose-Intranasal-COVID-19-Vaccine.html